Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Lexchin

Showing results (1-10 of 295) with videos related to

Pageof 30
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 14, 2017
Drug prices: How do we get to a better place?Joel Lexchin
Lancet (London, England)|February 25, 2003
Treating hyperkalaemiaJoel Lexchin
International Journal of Health Services : Planning, Administration, Evaluation|June 16, 2020
Drug Promotion in India Since 2000: Problems RemainJoel Lexchin
BMJ Open|July 6, 2021
Time to market for drugs approved in Canada between 2014 and 2018: an observational studyJoel Lexchin
JAMA Internal Medicine|November 20, 2023
Therapeutic Benefit From New Drugs From Pharmaceutical CompaniesJoel Lexchin
Medicine and Law|November 1, 2007
The secret things belong unto the Lord our God: secrecy in the pharmaceutical arenaJoel Lexchin
CJEM|September 30, 2011
Ban drug advertisementsJoel Lexchin
International Journal of Health Services : Planning, Administration, Evaluation|March 13, 2012
Harmony in drug regulation, but who's calling the tune? An examination of regulatory harmonization in health CanadaJoel Lexchin
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 23, 2005
A hypertensive snow birdJoel Lexchin
The International Journal of Risk & Safety in Medicine|September 28, 2015
Formulary status of drugs in Ontario after Health Canada has issued a serious safety warning: a cohort studyJoel Lexchin
Pageof 30

Showing results (1-10 of 295) with videos related to

Sort By:
Pageof 30
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 14, 2017
Drug prices: How do we get to a better place?Joel Lexchin
Lancet (London, England)|February 25, 2003
Treating hyperkalaemiaJoel Lexchin
International Journal of Health Services : Planning, Administration, Evaluation|June 16, 2020
Drug Promotion in India Since 2000: Problems RemainJoel Lexchin
BMJ Open|July 6, 2021
Time to market for drugs approved in Canada between 2014 and 2018: an observational studyJoel Lexchin
JAMA Internal Medicine|November 20, 2023
Therapeutic Benefit From New Drugs From Pharmaceutical CompaniesJoel Lexchin
Medicine and Law|November 1, 2007
The secret things belong unto the Lord our God: secrecy in the pharmaceutical arenaJoel Lexchin
CJEM|September 30, 2011
Ban drug advertisementsJoel Lexchin
International Journal of Health Services : Planning, Administration, Evaluation|March 13, 2012
Harmony in drug regulation, but who's calling the tune? An examination of regulatory harmonization in health CanadaJoel Lexchin
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 23, 2005
A hypertensive snow birdJoel Lexchin
The International Journal of Risk & Safety in Medicine|September 28, 2015
Formulary status of drugs in Ontario after Health Canada has issued a serious safety warning: a cohort studyJoel Lexchin
Pageof 30